Pulmonx CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
Pulmonx Corporation has issued its proxy statement detailing the agenda for its 2026 Annual Meeting of Stockholders, including director elections and ratification of its independent auditor.
NASDAQ
Pulmonx Corporation has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.
NASDAQ
Pulmonx Corporation's proxy statement details the agenda for the 2025 Annual Meeting of Stockholders, including director elections, auditor ratification, and executive compensation approval.
NASDAQ
Pulmonx Corporation has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.
NASDAQ
Pulmonx Corporation has scheduled its 2024 Annual Meeting of Stockholders for May 16, 2024, to elect directors, ratify the selection of an independent accounting firm, and conduct an advisory vote on executive compensation.